CO2017010808A2 - Sistemas y métodos para la vigilancia activa del cancer de próstata - Google Patents

Sistemas y métodos para la vigilancia activa del cancer de próstata

Info

Publication number
CO2017010808A2
CO2017010808A2 CONC2017/0010808A CO2017010808A CO2017010808A2 CO 2017010808 A2 CO2017010808 A2 CO 2017010808A2 CO 2017010808 A CO2017010808 A CO 2017010808A CO 2017010808 A2 CO2017010808 A2 CO 2017010808A2
Authority
CO
Colombia
Prior art keywords
systems
prostate cancer
methods
active surveillance
surveillance
Prior art date
Application number
CONC2017/0010808A
Other languages
English (en)
Inventor
Hans Lilja
Peter T Scardino
Andrew J Vickers
Yan Dong
Daniel Sjoberg
Original Assignee
Opko Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opko Diagnostics Llc filed Critical Opko Diagnostics Llc
Publication of CO2017010808A2 publication Critical patent/CO2017010808A2/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N7/00—Computing arrangements based on specific mathematical models
    • G06N7/01—Probabilistic graphical models, e.g. probabilistic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Databases & Information Systems (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Evolutionary Computation (AREA)
  • Probability & Statistics with Applications (AREA)
  • Mathematical Physics (AREA)

Abstract

RESUMEN Aspectos de la divulgación se refieren a métodos y sistemas mejorados para la vigilancia activa de un sujeto que tiene cáncer de próstata no agresivo.
CONC2017/0010808A 2015-04-29 2017-10-24 Sistemas y métodos para la vigilancia activa del cancer de próstata CO2017010808A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562154616P 2015-04-29 2015-04-29
PCT/US2016/029959 WO2016176529A1 (en) 2015-04-29 2016-04-29 Compositions and methods for active surveillance of prostate cancer

Publications (1)

Publication Number Publication Date
CO2017010808A2 true CO2017010808A2 (es) 2018-04-19

Family

ID=57198800

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0010808A CO2017010808A2 (es) 2015-04-29 2017-10-24 Sistemas y métodos para la vigilancia activa del cancer de próstata

Country Status (21)

Country Link
US (2) US20160320394A1 (es)
EP (2) EP3247387A4 (es)
JP (1) JP6873916B2 (es)
KR (1) KR102527446B1 (es)
CN (1) CN107530412A (es)
AU (1) AU2016254127B2 (es)
BR (1) BR112017022391A2 (es)
CA (1) CA2982262A1 (es)
CL (1) CL2017002701A1 (es)
CO (1) CO2017010808A2 (es)
DE (1) DE202016008673U1 (es)
EA (1) EA039028B1 (es)
HK (2) HK1247559A1 (es)
IL (1) IL254833B (es)
MX (1) MX2017013881A (es)
MY (1) MY197117A (es)
PE (1) PE20180930A1 (es)
SG (1) SG11201708289TA (es)
TW (1) TWI766836B (es)
UA (1) UA125745C2 (es)
WO (1) WO2016176529A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2812260T3 (es) 2009-02-02 2021-03-16 Opko Diagnostics Llc Estructuras para controlar la interacción de luz con dispositivos microfluídicos
BR112014021776B1 (pt) 2012-03-05 2022-08-09 Opko Diagnostics, Llc Sistema de ensaio e método para a determinação de uma probabilidade de um evento associado com o câncer da próstata
SG10201808585TA (en) 2014-03-28 2018-11-29 Opko Diagnostics Llc Compositions and methods related to diagnosis of prostate cancer
ES2867798T3 (es) 2015-03-27 2021-10-20 Opko Diagnostics Llc Estándares del antígeno prostático y usos de estos
EP3387447A4 (en) 2015-12-11 2019-08-28 Opko Diagnostics, LLC FLUID SYSTEMS WITH INCUBATION SAMPLES AND / OR REAGENTS
WO2017116979A1 (en) 2015-12-29 2017-07-06 Opko Diagnostics, Llc Fluid collection device and related methods
EP3794354A4 (en) * 2018-05-16 2022-01-12 Opko Diagnostics, LLC METHODS OF DETECTING PROSTATE CANCER ASSOCIATED WITH NEGATIVE RESULTS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211397B2 (en) * 1999-04-30 2007-05-01 Beckman Coulter, Inc. Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
WO2011027310A1 (en) * 2009-09-03 2011-03-10 Koninklijke Philips Electronics N.V. Novel tumor markers
MX2012012066A (es) 2010-04-16 2012-12-17 Opko Diagnostics Llc Control de retroalimentacion en sistemas microfluidicos.
BR112014021776B1 (pt) * 2012-03-05 2022-08-09 Opko Diagnostics, Llc Sistema de ensaio e método para a determinação de uma probabilidade de um evento associado com o câncer da próstata
EP2850432A2 (en) 2012-05-16 2015-03-25 Phadia AB Method for indicating the presence or non-presence of prostate cancer
CA2891394C (en) * 2012-11-20 2023-03-14 Phadia Ab Prognostic method for individuals with prostate cancer
JP2016503301A (ja) * 2012-11-20 2016-02-04 ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ 侵攻性前立腺癌の存在または不存在を判定する方法

Also Published As

Publication number Publication date
TW201705028A (zh) 2017-02-01
BR112017022391A2 (pt) 2018-07-10
EP3247387A1 (en) 2017-11-29
HK1247824A1 (zh) 2018-10-05
CN107530412A (zh) 2018-01-02
IL254833A0 (en) 2017-12-31
CL2017002701A1 (es) 2018-07-06
US20160320394A1 (en) 2016-11-03
KR102527446B1 (ko) 2023-05-02
US20220399121A1 (en) 2022-12-15
PE20180930A1 (es) 2018-06-08
UA125745C2 (uk) 2022-06-01
EP3287786A2 (en) 2018-02-28
JP2018518661A (ja) 2018-07-12
AU2016254127B2 (en) 2022-05-26
EA039028B1 (ru) 2021-11-24
CA2982262A1 (en) 2016-11-03
KR20180018514A (ko) 2018-02-21
MX2017013881A (es) 2018-03-12
WO2016176529A1 (en) 2016-11-03
MY197117A (en) 2023-05-26
JP6873916B2 (ja) 2021-05-19
TWI766836B (zh) 2022-06-11
EP3247387A4 (en) 2018-09-12
EP3287786A3 (en) 2018-03-21
DE202016008673U1 (de) 2019-01-22
SG11201708289TA (en) 2017-11-29
AU2016254127A1 (en) 2017-10-26
IL254833B (en) 2021-12-01
HK1247559A1 (zh) 2018-09-28
EA201792372A1 (ru) 2018-03-30

Similar Documents

Publication Publication Date Title
PH12020551397A1 (en) Cot modulators and methods of use thereof
CO2017010808A2 (es) Sistemas y métodos para la vigilancia activa del cancer de próstata
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12016501763A1 (en) Multispecific antibodies
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
CL2016001708A1 (es) Determinantes de respuesta del cáncer a la inmunoterapia
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
CL2016000354A1 (es) Modulación de la inmunidad tumoral
MY184870A (en) Immunomodulators
CL2015002562A1 (es) Anticuerpos e inmunoconjugados anti-b7-h4
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
GB201617037D0 (en) Management of group-sourced contacts directories, systems and methods
CR20150495A (es) Procesos para la preparación de un agente inductor de la apoptosis
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
AU363883S (en) Tracking device
CO2017001387A2 (es) Proceso para purificación de rhu-gcsf
MX2016015163A (es) Biomarcadores mit y metodos para su uso.
GB2569488A (en) PD-1 specific aptamers
AU352731S (en) Safety apparatus
MY187959A (en) Reactor
AU363245S (en) Spider trap
CO2017008424A2 (es) Protector de ánodo
CL2017002653A1 (es) Procedimiento y reactor para fijar arsénico.
MX2017001929A (es) Activacion del factor x.
UA114708U (uk) Тяговий привід електробуса